Illness severity scoring in status epilepticus-When STESS meets APACHE II, SAPS II, and SOFA
- PMID: 30585317
- DOI: 10.1111/epi.14623
Illness severity scoring in status epilepticus-When STESS meets APACHE II, SAPS II, and SOFA
Abstract
Objective: To characterize a critically ill cohort with status epilepticus (SE) by the illness severity scoring systems SAPS II (Simplified Acute Physiology Score II), APACHE II (Acute Physiology and Chronic Health Evaluation II), and SOFA (Sequential Organ Failure Assessment), and to compare their performance with the STESS (Status Epilepticus Severity Score) for outcome prediction.
Methods: The prospective cohort study was carried out at the University Hospital Basel, a Swiss tertiary academic medical care center. Consecutive adult SE patients hospitalized in the intensive care units from 2011 to 2016 were included. Illness severity scores and additional clinical data were recorded. Logistic regression models using automated variable selection were applied to identify scores associated with no return to functional and neurological baseline and death. Measures of discrimination and calibration were assessed.
Results: Among 184 patients, 33% returned to baseline. Median scores of the illness severity scores were within the lowest third of the possible scoring ranges, and all differed significantly between patients with and without return to baseline. The areas under the receiver operating curves for the prediction of no return to baseline and death ranged from 0.64 to 0.73, with the highest value for the STESS predicting no return to baseline. Measures of calibration revealed adequate model fit for all analyses. Among integral components of the scoring systems, only the Glasgow Coma Scale (GCS) differed significantly between patients with and without return to baseline. In multivariable analyses, decreasing GCS and increasing STESS had the strongest associations (odds ratio [OR] = 0.84, 95% confidence interval [CI] = 0.77-0.93 and OR = 1.34, 95% CI = 1.05-1.68, respectively) with no return to baseline independent of all other scoring systems, whereas the APACHE II revealed the strongest association with death (OR = 1.15, 95% CI = 1.06-1.25).
Significance: Although complex illness severity scoring systems in SE patients facilitate benchmarking and comparisons with other severely ill patient cohorts, they offer no advantages over the STESS and GCS regarding prediction of no return to baseline.
Keywords: neurocritical care; outcome prediction; scoring systems; status epilepticus.
Wiley Periodicals, Inc. © 2018 International League Against Epilepsy.
Similar articles
-
Severity scores for status epilepticus in the ICU: systemic illness also matters.Crit Care. 2023 Jan 16;27(1):19. doi: 10.1186/s13054-022-04276-7. Crit Care. 2023. PMID: 36647138 Free PMC article.
-
Common intensive care scoring systems do not outperform age and glasgow coma scale score in predicting mid-term mortality in patients with spontaneous intracerebral hemorrhage treated in the intensive care unit.Scand J Trauma Resusc Emerg Med. 2017 Oct 25;25(1):102. doi: 10.1186/s13049-017-0448-z. Scand J Trauma Resusc Emerg Med. 2017. PMID: 29070068 Free PMC article.
-
Predictive value of the APACHE II, SAPS II, SOFA and GCS scoring systems in patients with severe purulent bacterial meningitis.Anaesthesiol Intensive Ther. 2016;48(3):175-9. doi: 10.5603/AIT.a2016.0030. Epub 2016 May 30. Anaesthesiol Intensive Ther. 2016. PMID: 27240026
-
Predicting outcome of status epilepticus.Epilepsy Behav. 2015 Aug;49:126-30. doi: 10.1016/j.yebeh.2015.04.066. Epub 2015 Jun 10. Epilepsy Behav. 2015. PMID: 26071999 Review.
-
Severity scores in respiratory intensive care: APACHE II predicted mortality better than SAPS II.Respir Care. 1995 Oct;40(10):1042-7. Respir Care. 1995. PMID: 10152703 Review.
Cited by
-
The relationship and threshold of serum phosphate with regard to the 28-day mortality risk in sepsis patients undergoing continuous renal replacement therapy.J Int Med Res. 2020 Jan;48(1):300060519831896. doi: 10.1177/0300060519831896. Epub 2019 Feb 28. J Int Med Res. 2020. PMID: 30819019 Free PMC article.
-
Hypoalbuminemia in status epilepticus is a biomarker of short- and long-term mortality: A 9-year cohort study.Eur J Neurol. 2025 Jan;32(1):e16573. doi: 10.1111/ene.16573. Eur J Neurol. 2025. PMID: 39711115 Free PMC article.
-
Impact of frailty, biomarkers and basic biochemical parameters on outcomes of comatose patients in status epilepticus: a single-center prospective pilot study.BMC Neurol. 2024 Jan 26;24(1):46. doi: 10.1186/s12883-024-03537-y. BMC Neurol. 2024. PMID: 38279084 Free PMC article.
-
Retrospective External Validation of the Status Epilepticus Severity Score (STESS) to Predict In-hospital Mortality in Adults with Nonhypoxic Status Epilepticus: A Machine Learning Analysis.Neurocrit Care. 2023 Apr;38(2):254-262. doi: 10.1007/s12028-022-01610-3. Epub 2022 Oct 13. Neurocrit Care. 2023. PMID: 36229575
-
Correlation between mortality and blood transfusion in patients with major surgery initially admitted to intensive care unit: a retrospective analysis.BMC Anesthesiol. 2023 Sep 4;23(1):298. doi: 10.1186/s12871-023-02261-3. BMC Anesthesiol. 2023. PMID: 37667179 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources